{"id":7426,"date":"2026-07-02T10:15:10","date_gmt":"2026-07-02T10:15:10","guid":{"rendered":"https:\/\/dexpatent.com\/insights\/?p=7426"},"modified":"2026-07-02T10:17:11","modified_gmt":"2026-07-02T10:17:11","slug":"neurosense-japanese-patent-primec","status":"publish","type":"post","link":"https:\/\/dexpatent.com\/insights\/2026\/07\/02\/neurosense-japanese-patent-primec\/","title":{"rendered":"NeuroSense Therapeutics receives Japanese Patent for PrimeC Novel Composition"},"content":{"rendered":"

\"NeuroSense<\/p>\n

NeuroSense Therapeutics receives Japanese Patent for PrimeC Novel Composition<\/h2>\n

NeuroSense Therapeutics receives Japanese Patent for a novel composition for treating amyotrophic lateral sclerosis (ALS). The patent discloses PrimeC’s proprietary formulation and manufacturing process, including its synchronized delivery profile of celecoxib and ciprofloxacin, designed to target multiple key mechanisms underlying ALS progression. (Source \u2013 Prnewswire)<\/em><\/p>\n

General Motor patents a new seat that massages tired legs<\/h2>\n

General Motors has filed a patent application<\/a> for a seat that massages thighs and calves through a special leg support. This patent describes a massage system designed to extend therapeutic treatment beyond the back and lower spine to the thighs and calves of the legs, through a dedicated support integrated in front of the seat cushion. (Source \u2013 Speedme)<\/em><\/p>\n

Genprex\u2019s Reqorsa combo secures Canadian patent for lung cancer<\/h2>\n

Genprex has received a Canadian Patent for its Reqorsa Gene Therapy in combination with either programmed cell death protein 1 (PD-1) or PD-L1 antibodies. This combination is used to treat non-small cell lung cancer (NSCLC) and small cell lung cancer (SCLC). (Source \u2013 Pharmaceutical-technology)<\/em><\/p>\n

Protiviti Awarded Second U.S. Patent for AI-Powered Questionnaire Automation and Data Matching System<\/h2>\n

Protiviti has received a second U.S. patent for its innovation titled “Systems and Methods for Automated Data Set Matching Services.” The patent uses artificial intelligence (AI) and machine learning (ML)<\/a> to help organizations automate and streamline high-volume questionnaire response processes. (Source \u2013 Prnewswire)<\/em><\/p>\n

\"Patent<\/a><\/p>\n

Faraday Future secures US patent for hybrid transmission system<\/h2>\n

Faraday Future Intelligent Electric Inc. has secured a U.S. patent for a range-extending hybrid transmission system. The patent relates to a multi-clutch and multi-shaft architecture designed to decouple the engine, generator-motor, and drive wheels, allowing them to operate concurrently or independently. (Source \u2013 Scanx.trade)<\/em><\/p>\n

Viettel AI receives US patent for masked facial recognition technology<\/h2>\n

Viettel AI, the AI research arm of Vietnam\u2019s military-run industry and telecoms group Viettel, has received a U.S. patent for an AI-based facial recognition method. This method improves facial recognition accuracy by using AI and identifies users wearing face masks. (Source \u2013 News.tuoitre)<\/em><\/p>\n

Tesla Cybercab patents a unique wheel design<\/h2>\n

Tesla patents ornamental design for its cybercab wheels. The patented wheel design is defined by a flat, gold hubcap that snaps over the rim, closing off air pockets to maximize aerodynamic efficiency. (Source \u2013 Notateslaapp)<\/em><\/p>\n

Datavault AI Secures Patent for Tokenized Asset Systems<\/h2>\n

Datavault AI Inc has received a patent relating to tokenized asset systems. The patent application<\/a> covers critical areas including minting and authenticating of tokenized assets. It also encompasses ownership records and token utilization across multiple platforms and exchanges. (Source \u2013 Harianbasis)<\/em><\/p>\n","protected":false},"excerpt":{"rendered":"

NeuroSense Therapeutics receives Japanese Patent for PrimeC Novel Composition NeuroSense Therapeutics receives Japanese Patent for a novel composition for treating amyotrophic lateral sclerosis (ALS). The patent discloses PrimeC’s proprietary formulation and manufacturing process, including its synchronized delivery profile of celecoxib and ciprofloxacin, designed to target multiple key mechanisms underlying ALS […]<\/p>\n","protected":false},"author":1,"featured_media":7427,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"nf_dc_page":"","om_disable_all_campaigns":false,"rop_custom_images_group":[],"rop_custom_messages_group":[],"rop_publish_now":"no","rop_publish_now_accounts":[],"rop_publish_now_history":[],"rop_publish_now_status":"pending","_monsterinsights_skip_tracking":false,"_monsterinsights_sitenote_active":false,"_monsterinsights_sitenote_note":"","_monsterinsights_sitenote_category":0,"footnotes":""},"categories":[2],"tags":[428,429,427],"class_list":["post-7426","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-patentnewzbox","tag-japanesepatent","tag-neurosense","tag-primec"],"aioseo_notices":[],"aioseo_head":"\n\t\t\n\t\n\t\n\t\n\t\n\t\n\t\t\n\t\t\n\t\t\n\t\t\n\t\t\n\t\t\n\t\t\n\t\t\n\t\t\n\t\t\n\t\t\n\t\t